MicroPort CardioFlow Medtech Corp logo

MicroPort CardioFlow Medtech Corp (2160)

Market Open
12 Jun, 08:00
HKEX HKEX
1. 48
HKD
-0.02
-1.3333%
HKD
1.67B Market Cap
- P/E Ratio
- Div Yield
456,600 Volume
- Eps
1.5 HKD
Previous Close
Add Transaction
Day Range
1.46 1.53
Year Range
1.43 8.45
Want to track 2160 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2160 trading today lower at 1.48 HKD, a decrease of -1.3333% from yesterday's close, completing a monthly decrease of -12.9412% or -0.22 HKD. Over the past 12 months, 2160 stock gained 23.3333%.
2160 is not paying dividends to its shareholders.
The last earnings report, released on Mar 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
MicroPort CardioFlow Medtech Corp has completed 2 stock splits, with the recent split occurring on Feb 24, 2026.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2160 Chart

People also search for

Viva Biotech Holdings
1.2 HKD
+0.8403%
Chaoju Eye Care Holdings Ltd.
2.54 HKD
0%
MicroTech Medical (Hangzhou) Co., Ltd.
7.34 HKD
0%
Town Health International Medical Group Ltd.
0.22 HKD
0%
Perfect Medical Health Management Ltd.
1.13 HKD
+1.8018%

MicroPort CardioFlow Medtech Corp (2160) FAQ

What is the stock price today?

The current price is 1.48 HKD.

On which exchange is it traded?

MicroPort CardioFlow Medtech Corp is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2160.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.67B.

Has MicroPort CardioFlow Medtech Corp ever had a stock split?

MicroPort CardioFlow Medtech Corp had 2 splits and the recent split was on Feb 24, 2026.

MicroPort CardioFlow Medtech Corp Profile

Health Care Technology Industry
Healthcare Sector
- CEO
HKEX Exchange
KYG6082P1054 ISIN
China Country
483 Employees
- Last Dividend
24 Feb 2026 Last Split
- IPO Date

Overview

MicroPort CardioFlow Medtech Corporation is a medical device company focused on the research, development, and commercialization of transcatheter and surgical solutions dedicated to treating structural heart diseases. With its operations centralized in the People’s Republic of China, the company has positioned itself as a major player within the medical device sector in the country. Since its establishment in 2010, MicroPort CardioFlow Medtech Corporation has been continuously advancing its product offerings to meet the needs of patients suffering from complex heart conditions, underscoring its commitment to innovation and excellence in the healthcare industry. Headquartered in Shanghai, China, the company is known for its development of state-of-the-art medical devices that are designed to improve the quality of life for patients with heart valve diseases.

Products and Services

  • Vitaflow Aortic Valve System

    This system represents a cutting-edge solution for patients in need of aortic valve replacement. The Vitaflow Aortic Valve System is designed for precision and efficacy, offering a minimally invasive alternative to traditional surgical valve replacement. Its state-of-the-art features allow for improved patient outcomes with reduced recovery times, making it a cornerstone product for the company in addressing aortic valve diseases.

  • Alwide Balloon Catheter

    The Alwide Balloon Catheter is a specialized device employed in the dilation of cardiac and peripheral vessels. This product is essential for procedures that require vessel expansion to facilitate the treatment of various heart and vascular conditions. Its design and functionality ensure that it meets the high standards required for such critical applications, reinforcing the company's commitment to providing comprehensive solutions for vascular interventions.

  • Alpass Introducer Set

    Designed to facilitate the introduction of devices into the body, the Alpass Introducer Set is a crucial tool in the minimally invasive surgery toolkit. Its application spans across a range of procedures, enabling the smooth and safe insertion of medical devices. This product underscores the company’s focus on developing procedural accessories that complement its primary offerings, enhancing overall procedural safety and effectiveness.

Contact Information

Address: No. 1661 Zhangdong Road
Phone: 86 21 3895 4600